Skip to main content
SpringerLink
Log in

A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission

Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Cite this article

Summary

A total of 19 Hodgkin's disease (HD) patients (12 male, 7 female) aged 26–67 years, who had been in complete unmaintained remission for 6 months or more when the study was initiated, were randomly given 50 mg thymostimulin (TS) i.m. daily (G1) or every other day (G2) for 35 days. A third group (G3) was not treated. Then TS, at the same dose was administered twice a week for the following 22 weeks in patients both initially receiving loading or intermittent TS treatment. When compared with age-and sex-matched controls, as a group, the patients' circulating OKT +3 , OKT +4 , OKT +11 and E-AETR+ cells were depressed (P<0.001 for both proportions and absolute numbers), whereas their OKT +8 cell population was not. Following 5 weeks of daily TS administration, the proportions and numbers of all T cell fractions significantly increased in G1 patients (P<0.03 for all the comparisons tested), while following intermittent TS treatment (G2) only the proportions of OKT +3 and OKT +11 cells (P<0.03), but not of other T cell fractions, significantly increased. In addition, no significant changes in the absolute numbers of T cell fractions were observed in this group of patients. Furthermore, no spontaneous variations in the T cell pool size occurred in untreated patients. TS maintenance therapy did not produce any further improvement in the size of overall T cells and T cell subsets but sustained percentage and absolute numbers of these cells during administration and the absolute number of T cells even after discontinuation of therapy. The TS-induced improvement in the T cell pool was not associated with any change in the size of circulating non-T lymphocytes and monocytes. In vitro phytohemagglutinin-induced interleukin-2 (IL-2) and gamma-interferon (IFN-γ) synthesis was assessed in 11 patients (3 G1, 4 G2, and 4 G3). Although it was not statistically significant, a rise in IL-2 and IFN-γ production was observed in TS-treated patients, but not in untreated controls. TS failed to exert any effect on the serum circulating levels of neopterin, type I and II IFN, beta-2 microglobulin (B2-M) and immunoglobulins (Ig). TS can thus improve defective T cell frequences and numbers and may modulate IL-2 and IFN-γ production.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Aiuti F, Ammirati P, Fiorilli M, D'Amelio R, Franchi F, Calvani M, Businco L (1979) Immunologic and clinical investigation on a bovine thymic extract. Therapeutic applications in primary immunodeficiencies. Pediatr Res 13:797

    Google Scholar 

  2. Bergesi G, Falchetti R (1977) Caratterizzazione chimica e attivitá biologica di un nuovo estratto timico. Folia Allergol Immunol Clin 24:204

    Google Scholar 

  3. Chang TW, McKinney S, Liu V, Kung PC, Vilcek J, Le J (1984) Use of monoclonal antibodies as sensitive and specific probes for biologically active human γ-interferon. Proc Natl Acad Sci USA 81:5219

    Google Scholar 

  4. Costanzi JJ, Gagliano RG, Delaney F, Harris N, Thurman GB, Sakai H, Goldstein AL, Loukas D, Cohen GB, Thomson PD (1977) The effect of thymosin on patients with disseminated malignancies. Cancer 40:14

    Google Scholar 

  5. Falchetti R, Bergesi G, Eshkol A, Cafiero C, Adorini L, Caprino L (1977) Pharmacological and biological properties of a calf thymus extract (TP-1). Drugs Exptl Clin Res 3:39

    Google Scholar 

  6. Ford RJ, Tsao J, Kouttab NM, Sahasrabuddhe CG, Mehta SR (1984) Association of an interleukin abnormality with the T cell defect in Hodgkin's disease. Blood 64:386

    Google Scholar 

  7. Fuchs D, Hausen A, Knosp O, Reibnegger G, Wachter H, Kofler M, Kosahowsky H, Huber Ch, Niederwieser D (1983) Neopterin evaluation in patients suffering from pulmonary tuberculosis. In: Biochemical and clinical aspects of pteridines. Walter de Gruyter, Berlin, New York, p 281

    Google Scholar 

  8. Gastl G, Aulitzky W, Tilg H, Nachbaur K, Troppmair J, Flener R, Huber Ch (1986) A biological approach to optimize interferon treatment in hairy cell leukemia. Immunobiology 172:262

    Google Scholar 

  9. Goldstein AL, Low TLK, Thurman GB (1982) Thymosins and other hormone-like factors of the thymus gland. In: Immunological approaches to cancer therapeutics. Wiley, New York p 137

    Google Scholar 

  10. Grinblat J, Schauenstein K, Saltz E, Trainin N, Globerson A (1983) Regulatory effects of thymus humoral factor on T cell growth factor in aging mice. Mech Ageing Dev 22:209

    Google Scholar 

  11. Hausen A, Fuchs D, Reibnegger G, Wachter H, Egg D, Günther R (1983) Neopterin as index for activity of disease in patients with rheumatoid arthritis. In: Biochemical and clinical aspects of pteridines. Walter De Gruyter, Berlin, New York, p 245

    Google Scholar 

  12. Huang KY, Kind PD, Jagoda EM, Goldstein AL (1981) Thymosin treatment modulates production of interferon. J Interferon Res 1:411

    Google Scholar 

  13. Huber Ch, Fuchs D, Hausen A, Margreiter R, Reibnegger G, Spielberger M, Wachter H (1983) Pteridines as a new marker to detect human T cells activated by allogeneic or modified self major histocompatibility complex (MHC) determinants. J Immunol 130:1047

    Google Scholar 

  14. Huber Ch, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D, Reibnegger G, Swetly P, Troppmair J, Wachter H (1984) Immune response-associated production of neopterin. Release from macrophages primarily under control of interferon-gamma. J Exp Med 160:310

    Article  CAS  PubMed  Google Scholar 

  15. Jameson P, Dixon MA, Grossberg SE (1977) A sensitive interferon assay for many species of cells: Encephalomyocarditis virus hemagglutinin yield reduction (39768). Proc Soc Exp Biol Med 155:173

    Google Scholar 

  16. Janossy G (1981) Membrane markers in leukemia. In: The leukemic cell. Churchill Livingstone, Edinburgh, London, Melbourne, New York, p 129

    Google Scholar 

  17. Liberati AM, Brugia M, Edwards BS, Bertoni P, Ballatori E, Puxeddu A, Grignani F (1985) Immunorestorative properties of thymostimulin (TS) in patients with Hodgkin's disease in clinical remission. Cancer Immunol Immunother 19:136

    Google Scholar 

  18. Liberati AM, Ballatori E, Fizzotti M, Schippa M, Proietti MG, Di Marzio R, Pecci A, Biscetti L, Sbarretti R, Cini L, Grignani F (1987) Immunologic profile in patients with Hodgkin's disease in complete remission. Cancer 59:1906

    Google Scholar 

  19. Low TLK, Thurman GB, Chincarini C, McClure JE, Marshall GD, Hu SK, Goldstein AL (1979) Current status of thymosin research: evidence for the existence of a family of thymic factors that control T cell maturation. Ann NY Acad Sci 332:33

    Google Scholar 

  20. Margreiter R, Fuchs D, Hausen A, Huber C, Reibnegger G, Spielberger M, Wachter H (1983) Neopterin as a new biochemical marker for diagnosis of allograft rejection. Experience based upon evaluation of 100 consecutive cases. Transplantation 36:650

    Google Scholar 

  21. Martelli MF, Velardi A, Rambotti P, Cernetti C, Bracaglia AM, Ballatori E, Davis S (1982) The in vitro effect of a calf thymus extract (thymostimulin) on the immunologic parameters of patients with untreated Hodgkin's disease. Cancer 49:245

    Google Scholar 

  22. Martelli MF, Velardi A, Rambotti P, Cernetti C, Bertotto A, Spinozzi F, Bracaglia AM, Falini B, Davis S (1982) The in vivo effect of a thymic factor (thymostimulin) on immunologic parameters of patients with untreated Hodgkin's disease. Cancer 50:490

    Google Scholar 

  23. Meuer SC, Hussey RE, Penta AC, Fitzgerald KA, Stalder BM, Schlossman SF, Reinherz EL (1982) Cellular origin of interleukin 2 (IL-2) in man: evidence for stimulus-restricted IL-2 production by T4+ and T8+ T lymphocytes. J Immunol 129:1076

    Google Scholar 

  24. Neauport-Sautes C, Bismuth A, Kourilsky FM, Manuel Y (1974) Relationship between HL-A antigens and β2-microglobulin as studied by immunofluorescence on the lymphocyte membrane. J Exp Med 139:957

    Google Scholar 

  25. Neta R, Salvin SB (1983) Resistance and susceptibility to infection in inbred murine strains. II Variations in the effect of treatment with thymosin fraction 5 on the release of lymphokines in vivo. Cell Immunol 75:173

    Google Scholar 

  26. Palacios R (1983) Role of serum thymic factor (FTS) in the development of interleukin-2 producer lymphocytes. Clinics Immunol Allergy 3:83

    Google Scholar 

  27. Palacios R, Fernandez C, Sideras P (1982) Development and continuous growth in culture of interleukin 2-producer lymphocytes from athymic nu/nu mice. Eur J Immunol 12:777

    Google Scholar 

  28. Schulof RS (1985) Thymic peptide hormones: basic properties and clinical applications in cancer. CRC Crit Rev Oncol Hematol 3:309

    Google Scholar 

  29. Schulof RS, Goldstein AL (1981) Thymosins and other thymic hormones. In: Lymphokines. Clifton, New Jersey, Humana Press, p 397

    Google Scholar 

  30. Schulof RS, Goldstein AL (1983) Clinical applications of thymosin and other thymic hormones. In: Recent advances in clinical immunology. New York, Churchill Livingstone p 243

    Google Scholar 

  31. Schulof RS, Lloyd MJ, Cleary PA, Palaszynski SR, Mai DA, Cox JW Jr, Alabaster O, Goldstein AL (1985) A randomized trial to evaluate the immunorestorative properties of synthetic thymosin-α1 in patients with lung cancer. J Biol Resp Mod 4:147

    Google Scholar 

  32. Shoham J, Eshel I, Mordechai A, Salzberg S (1980) Thymic hormonal activity on human peripheral blood lymphocytes in vitro. II. Enhancement of the production of immune interferon by activated cells. J Immunol 125:54

    Google Scholar 

  33. Soulillou JP, Douillard JY, Vie H, Harousseau JL, Guenel J, Le Mevelle Pourhiet A, Le Mevel B (1985) Defect in lectin-induced interleukin 2 (IL-2) production by peripheral blood lymphocytes of patients with Hodgkin's disease. Eur J Cancer Clin Oncol 21:935

    Google Scholar 

  34. Svedersky LP, Hui A, May L, McKay P, Stebbing N (1982) Induction and augmentation of mitogen-induced immune interferon production in human peripheral blood lymphocytes by N α-desacetylthymosin-α1. Eur J Immunol 12:244

    Google Scholar 

  35. Tovo PA, Bernengo MG, Cordero di Montezemolo L, Del Piano A, Saitta M, Nicola P (1980) Thymus extract therapy in immunodepressed patients with malignancies and herpes virus infections. Thymus 2:41

    Google Scholar 

  36. Vitetta ES, Poulik MD, Klein J, Uhr JW (1976) Beta 2-microglobulin is selectively associated with H-2 and TL alloantigens on murine lymphoid cells. J Exp Med 144:179

    Google Scholar 

  37. Wachter H, Hausen A, Grassmayr K (1979) Erhöhte Ausscheidung von Neopterin im Harn von Patienten mit malignen Tumoren und mit Viruserkrankungen. Hoppe-Seyler's Z Physiol Chem 360:1957

    Google Scholar 

  38. Zatz MM, Oliver J, Sztein MB, Skotnicki AB, Goldstein AL (1985) Comparison of the effects of thymosin and other thymic factors on modulation of interleukin-2 production. J Biol Resp Modif 4:365

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica Medica I, Università degli Studi di Perugia, Policlinico Monteluce, I-06100, Perugia, Italy

    A. M. Liberati, M. Fizzotti, M. Schippa, L. Cini, S. Cinieri, M. Senatore & F. Grignani

  2. Dipartimento di Statistica, Università di Perugia, Italy

    E. Ballatori

  3. Servizio di Medicina Nucleare, Ospedale Civile, Terni, Italy

    M. G. Proietti & R. Di Marzio

Authors
  1. A. M. Liberati
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Ballatori
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Fizzotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Schippa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. L. Cini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. S. Cinieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. G. Proietti
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. R. Di Marzio
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. M. Senatore
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. F. Grignani
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Liberati, A.M., Ballatori, E., Fizzotti, M. et al. A randomized trial to evaluate the immunorestorative properties of thymostimulin in patients with Hodgkin's disease in complete remission. Cancer Immunol Immunother 26, 87–93 (1988). https://doi.org/10.1007/BF00199853

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199853

Keywords

search

Navigation